周二,Piper Sandler的分析师将Becton Dickinson(纽约证券交易所代码:BDX)的股票目标价从275美元上调至280美元,同时维持"增持"评级。这一调整是在Becton Dickinson股票表现不佳的一段时期之后做出的。在过去六年多的时间里,该公司的股票表现落后于iShares U.S. Medical Devices ...
新泽西州富兰克林湖 - 全球医疗技术公司BD(Becton, Dickinson and Company) (NYSE: BDX)今日宣布季度股息和额外股票回购授权。该公司市值为724.7亿美元,其董事会宣布每普通股季度股息1.04美元,年化股息率为4.16美元,收益率为1.67%。股息将于2025年3月31日支付给截至2025年3月10日的在册股东。根据 InvestingPro ...
Piper Sandler raised the firm’s price target on Becton Dickinson (BDX) to $280 from $275 and keeps an Overweight rating on the shares. The firm ...
In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Becton Dickinson (BDX – Research Report), with a price ...
Piper Sandler's analysts increased the price target for Becton Dickinson (NYSE:BDX) shares to $280 from $275, while ...
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $243.45 which represents a slight increase of $2.98 or 1.24% from the prior close of $240.47. The stock opened at $239 and ...
Brighton Jones LLC raised its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 98.2% in the ...
Atomi Financial Group Inc. lifted its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 25.3% in the ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy ...
In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...